journal article·2020-12

Accurate Cancer Diagnosis and Stage Monitoring Enabled by Comprehensive Profiling of Different Types of Exosomal Biomarkers: Surface Proteins and miRNAs

Sisi Zhou, Tao Hu, Gaohua Han, Yafeng Wu, Xin Hua, Juan Su, Weiwei Jin, Yiping Mou, Xiaozhou Mou, Quan Li, Songqin Liu

Small· Volume 16· Issue 48
Publisher page

Abstract

Abstract Exosomes are recognized as promising biomarkers for early cancer diagnosis and prognosis owing to a large amount of biological information they carried. But the key is that single type of exosomal biomarker analysis is not sufficient enough for accurate cancer diagnosis and stage monitoring due to the insufficient information and high false positive signal. To address the challenge, here simultaneous in situ detection of different types of exosomal biomarkers (surface proteins: CD81, ephrin type‐A receptor 2, and carbohydrate antigen 19‐9; miRNAs: miR‐451a, miR‐21, and miR‐10b) is conducted with a 3D microfluidic chip, which works in conjunction with quantum dot (QD) labeling and vesicle fusion technology. After exosomes are efficiently captured by the microfluidic chip, the quantification of multiple exosomal proteins is achieved by using three kinds of QDs with the same excitation and different emission wavelengths, and virus‐mimicking fusogenic vesicles encapsulating three exquisitely engineered molecular beacons are introduced for ultrasensitive detection of multiple exosomal miRNAs without requiring RNA extraction. Through comprehensive profiling different types of exosomal biomarkers, the false positive rate is substantially avoided and the accuracy of cancer diagnosis and stage monitoring is improved to ≈100%, which are critical to cancer effective treatment and favorable prognosis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Microfluidic and Bio-sensing Technologies · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Environmental Medicine Engineering Ministry of Education Jiangsu Engineering Laboratory of Smart Carbon‐Rich Materials and Device Jiangsu Key Laboratory for Design and Manufacture of Micro/Nano Biomedical Instruments School of Chemistry and Chemical Engineering Southeast University Nanjing 211189 China

Taizhou People's Hospital Taizhou 225300 China

Department of Gastrointestinal and Pancreatic Surgery Key Laboratory of Gastroenterology of Zhejiang Province Zhejiang Provincial People's Hospital Hangzhou 310014 China

College of Chemistry and Materials Science Sichuan Normal University Chengdu Sichuan 610068 China

Funding

National Natural Science Foundation of China · National Basic Research Program of China · Fundamental Research Funds for the Central Universities

References (42)

Show source-provided references
1. 10.1038/s41571-018-0036-910.1038/s41571-018-0036-9 ↗
2. 10.1038/ncb180010.1038/ncb1800 ↗
3. 10.1021/nn404945r10.1021/nn404945r ↗
4. 10.1186/1471-2164-14-31910.1186/1471-2164-14-319 ↗
5. 10.1208/s12248-018-0201-110.1208/s12248-018-0201-1 ↗
6. 10.1007/s12094-016-1599-510.1007/s12094-016-1599-5 ↗
7. 10.1038/nbt.288610.1038/nbt.2886 ↗
8. 10.1021/acs.nanolett.9b0223210.1021/acs.nanolett.9b02232 ↗
9. 10.1002/anie.20170380710.1002/anie.201703807 ↗
10. 10.1038/s41467-017-02261-110.1038/s41467-017-02261-1 ↗
11. 10.1158/1078-0432.CCR-17-057710.1158/1078-0432.CCR-17-0577 ↗
12. 10.1021/acsnano.5b0452710.1021/acsnano.5b04527 ↗
13. 10.18632/oncotarget.1948210.18632/oncotarget.19482 ↗
14. 10.1016/j.bios.2019.11174910.1016/j.bios.2019.111749 ↗
15. 10.1021/acs.analchem.8b0327210.1021/acs.analchem.8b03272 ↗
16. 10.1021/acsnano.5b0758410.1021/acsnano.5b07584 ↗
17. 10.1021/acsnano.7b0508310.1021/acsnano.7b05083 ↗
18. 10.1039/C4LC00136B10.1039/C4LC00136B ↗
19. 10.1021/acsami.9b0140610.1021/acsami.9b01406 ↗
20. 10.1039/c3lc41343h10.1039/c3lc41343h ↗
21. 10.1021/acsnano.6b0613110.1021/acsnano.6b06131 ↗
22. 10.1039/C9LC00445A10.1039/C9LC00445A ↗
23. 10.1073/pnas.170921011410.1073/pnas.1709210114 ↗
24. 10.1021/acsnano.7b0227710.1021/acsnano.7b02277 ↗
25. 10.1039/C6LC00279J10.1039/C6LC00279J ↗
26. 10.1021/nn405016y10.1021/nn405016y ↗
27. 10.1039/C5LC00036J10.1039/C5LC00036J ↗
28. 10.1021/acs.analchem.9b0485210.1021/acs.analchem.9b04852 ↗
29. 10.1039/C5LC01117E10.1039/C5LC01117E ↗
30. 10.1021/acsami.8b1397110.1021/acsami.8b13971 ↗
31. 10.1016/j.biomaterials.2015.03.01410.1016/j.biomaterials.2015.03.014 ↗
32. 10.1126/science.106623810.1126/science.1066238 ↗
33. 10.1073/pnas.050797610310.1073/pnas.0507976103 ↗
34. 10.1038/s41467-017-02261-110.1038/s41467-017-02261-1 ↗
35. 10.1002/adma.20140467710.1002/adma.201404677 ↗
36. Kawamura S. · J. Hepato‐Bil‐Pan. Sci. · 2019 · 26 · 63
37. Goto T. · BMC Cancer · 2018 · 9 · 175
38. 10.1002/anie.20190199710.1002/anie.201901997 ↗
39. 10.1038/nchembio.251110.1038/nchembio.2511 ↗
40. 10.1039/c2lc20977b10.1039/c2lc20977b ↗
41. 10.1039/c0lc00162g10.1039/c0lc00162g ↗
42. 10.1016/j.bios.2016.06.05810.1016/j.bios.2016.06.058 ↗